These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1288961

  • 21. In vitro activity of the new fluoroquinolone CP-99,219.
    Neu HC, Chin NX.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2615-22. PubMed ID: 7872757
    [Abstract] [Full Text] [Related]

  • 22. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
    Chin NX, Neu HC.
    J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
    [Abstract] [Full Text] [Related]

  • 23. Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.
    Gargallo-Viola D, Ferrer S, Tudela E, Robert M, Coll R, Roser R, Guinea J.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3113-21. PubMed ID: 11600365
    [Abstract] [Full Text] [Related]

  • 24. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Louie A, Baltch AL, Ritz WJ, Smith RP.
    Chemotherapy; 1991 Nov; 37(4):275-82. PubMed ID: 1665123
    [Abstract] [Full Text] [Related]

  • 25. [Antibacterial activity of tosufloxacin against fresh clinical isolates].
    Yamashiro Y, Shimakura M, Minami S, Fukuoka Y, Yasuda T, Watanabe Y, Narita H, Akama M.
    Jpn J Antibiot; 1994 Mar; 47(3):245-54. PubMed ID: 8182895
    [Abstract] [Full Text] [Related]

  • 26. In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.
    Tanaka M, Yamazaki E, Chiba M, Yoshihara K, Akasaka T, Takemura M, Sato K.
    Antimicrob Agents Chemother; 2002 Mar; 46(3):904-8. PubMed ID: 11850285
    [Abstract] [Full Text] [Related]

  • 27. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
    Ito T, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
    [Abstract] [Full Text] [Related]

  • 28. In vitro activity of OPC-17116.
    Neu HC, Fang W, Gu JW, Chin NX.
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1310-5. PubMed ID: 1329620
    [Abstract] [Full Text] [Related]

  • 29. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone.
    Clement JJ, Tanaka SK, Alder J, Vojtko C, Beyer J, Hensey D, Ramer N, McDaniel D, Chu DT.
    Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740
    [Abstract] [Full Text] [Related]

  • 30. In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.
    Jones RN, Barry AL.
    Antimicrob Agents Chemother; 1990 Feb; 34(2):306-13. PubMed ID: 2327779
    [Abstract] [Full Text] [Related]

  • 31. Antimicrobial activity of CS-940, a new trifluorinated quinolone.
    Biedenbach DJ, Sutton LD, Jones RN.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2325-30. PubMed ID: 8619590
    [Abstract] [Full Text] [Related]

  • 32. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone.
    Wakabayashi E, Mitsuhashi S.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):594-601. PubMed ID: 8203860
    [Abstract] [Full Text] [Related]

  • 33. In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
    Cooper MA, Andrews JM, Wise R.
    J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603
    [Abstract] [Full Text] [Related]

  • 34. [In vitro antibacterial activities of broad spectrum quinolones against clinical bacterial isolates].
    Ishii Y, Ohno A, Yamaguchi K.
    Jpn J Antibiot; 1994 Jan; 47(1):22-8. PubMed ID: 8114270
    [Abstract] [Full Text] [Related]

  • 35. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 Jan; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 36. Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activity against gram-positive bacteria.
    Wakebe H, Mitsuhashi S.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2185-91. PubMed ID: 1332589
    [Abstract] [Full Text] [Related]

  • 37. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Oct; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 38. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
    Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
    [Abstract] [Full Text] [Related]

  • 39. In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
    Masuda N, Takahashi Y, Otsuki M, Ibuki E, Miyoshi H, Nishino T.
    Antimicrob Agents Chemother; 1996 May; 40(5):1201-7. PubMed ID: 8723467
    [Abstract] [Full Text] [Related]

  • 40. In vitro activity of Bay y 3118, a new quinolone.
    Fass RJ.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2348-57. PubMed ID: 8285618
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.